Drug Approvals – World’s Most Expensive Que 

$125 million

The cost of priority review, to save a few months of review time, paid to FDA by Sarepta Therapeutics in 2016.

$350 million

Priority review fee paid by AbbVie to FDA in 2015.

— Source: 

Gilead Goes to the Head of the Line

Leave a Reply

Your email address will not be published. Required fields are marked *

Best comments get a free hardcover copy of Living Sanely in an Insane World. We'll email you for your address if you're selected.